The systematic development of attributes and levels for a discrete choice experiment of HIV patient preferences for long-acting antiretroviral therapies in the United States.

Brah, Aaron T; Barthold, Douglas; Hauber, Brett; Collier, Ann C; Ho, Rodney J Y; Marconi, Vincent C; Simoni, Jane M; Graham, Susan M

Brah, Aaron T; Barthold, Douglas; Hauber, Brett; Collier, Ann C; Ho, Rodney J Y; Marconi, Vincent C; Simoni, Jane M; Graham, Susan M.

Afiliação

Brah AT; Division of Allergy & Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA. atbrah@uw.edu.
Barthold D; The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA.
Hauber B; The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute, University of Washington, Seattle, WA, USA.
Collier AC; Pfizer, Inc, New York, NY, USA.
Ho RJY; Division of Allergy & Infectious Diseases, Department of Medicine, University of Washington, Seattle, WA, USA.
Marconi VC; Department of Pharmaceutics and Bioengineering, University of Washington, Seattle, WA, USA.
Simoni JM; Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA, USA.
Graham SM; Department of Global Health, Rollins School of Public Health, Emory University, Atlanta, GA, USA.

AIDS Res Ther ; 19(1): 13, 2022 02 25.

Article em En | MEDLINE | ID: mdl-35216610

Assuntos

Infecções por HIV; Preferência do Paciente; Comportamento de Escolha; Infecções por HIV/tratamento farmacológico; Humanos; Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Preferência do Paciente Limite: Humans País como assunto: America do norte Idioma: En Ano de publicação: 2022 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google